• Latest Posts
More News! 26 Oct 2022

Neuraxpharm to commercialize device giving early warning of epileptic seizures

More News! 25 Oct 2022

Watch: NLS Days NLSInvest award winners – Asgard Therapeutics

More News! 24 Oct 2022

Sensorion gets go-ahead from France for trial of drug to prevent hearing loss

More News! 24 Oct 2022

Mass production of lutetium for targeted cancer therapeutics following collaboration

More News! 17 Oct 2022

Clinical trial of treatment for advanced solid tumors approved

More News! 14 Oct 2022

ChristianaCare spins out new gene-editing company CorriXR Therapeutics

ADVERTISEMENT
More News! 11 Oct 2022

First patient dosed in study of idiopathic pulmonary fibrosis

More News! 10 Oct 2022

Positive data indicates likely therapeutic effect of Alzheimer’s drug

More News! 10 Oct 2022

RadioMedix announces a $40 million series A financing for targeted alpha therapy platform

More News! 29 Sep 2022

Removing binding sites for an oncogene can slow cancer cell growth, researchers say

More News! 29 Sep 2022

Positive results from Eisai and Biogen Alzheimer’s trial

More News! 16 Sep 2022

Strategic collaboration for drug to treat NASH, obesity and diabetes announced

ADVERTISEMENT